Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom
Sytron 27.5 mg iron per 5 ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral solution. Clear, red syrup, free of particles. |
Each 5 ml of oral solution contains 207.5 mg of sodium feredetate trihydrate equivalent to 27.5 mg of iron.
Excipients with known effect:
Each 5 ml of Sytron solution contains: 5 mg of Methyl hydroxybenzoate (E218), 1 mg of Propyl Hydroxybenzoate (E216), 11.4 mg of sodium, 1400 mg of sorbitol, 0.015 ml of ethanol and 0.35 mg of Ponceau 4R (E124) - please refer to section 4.4 for further details.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sodium feredetate |
Sodium feredetate is used for iron deficiency anaemia. After absorption, elemental iron is available for haemoglobin regeneration and reversal of anaemia associated with iron-deficient states. |
| List of Excipients |
|---|
|
Methyl hydroxybenzoate (E218) |
Sytron is supplied in round amber glass bottles with a CRC cap. Each bottle contains either 125ml or 500ml or 2250ml of Sytron.
Not all pack sizes may be marketed.
Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom
PL 16508/0059
13 October 1993/18 February 2004
| Drug | Countries | |
|---|---|---|
| SYTRON | Estonia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
